Innovative Course Teaches How to Turn Ideas into Life Sciences Ventures
UCSF's “Idea to IPO” course is not a typical course. Instead, it’s an opportunity for students to bring their dreams and learn how to turn them into reality.
University of California San Francisco
Give to UCSFUCSF's “Idea to IPO” course is not a typical course. Instead, it’s an opportunity for students to bring their dreams and learn how to turn them into reality.
William Seeley maps the path of frontotemporal dementia through the brain, correlating specific damage with behavioral change. By studying the disease from self to circuits to cells, this visionary neurologist searches for inroads to treatment.
<p>Biomedical researchers at UCSF have won five of 51 prestigious National Institutes of Health Director’s New Innovator awards for high-risk, high-reward research, each receiving up to $1.5 million over five years.</p>
<p>Experts at UCSF and Caltech are pushing the boundaries of creative problem solving to address important clinical problems with the hope that the talent pool at both institutions, combined with an entrepreneurial spirit, will advance health care innovation.</p>
A panel of experts appointed by Mayor Gavin Newsom recently presented an action plan as the approaching “age wave may bring a potential crisis in Alzheimer’s and dementia care” to San Francisco.
UCSF Nobel laureate Elizabeth Blackburn, PhD, on Dec. 10 delivered a speech at the Nobel Banquet, where guests gathered in Stockholm City Hall to celebrate the accomplishments of the 2009 Nobel laureates.
Molecular biologist Elizabeth Blackburn joined Nobel laureates in Stockholm to discuss their discoveries and what their ongoing research tells us about health, cancer and aging.
Molecular biologist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco, received the 2009 Nobel Prize in Physiology or Medicine on December 10th, 2009 in Stockholm, Sweden.